The global inhalers market estimated to be valued US$ XX Mn in 2021 and poised to grow at significant CAGR over 2022-2028 due to technological progressions in the inhalers and rising governments alertness. Moreover, accumulative number of smokers and growing frequency of pulmonary diseases are the major factors driving the growth of the market. Furthermore, increasing pollution across the world, leads to increase in respiratory problems, which propels the growth of the market over the forecast years. Thisreport gives comprehensive outlook on inhalers across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. This report gives historical, current, and future market sizes (US$ Mn) on the basis of device type, application, inhaler type, end user, and region. This report studies the dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global inhalers market report include suppliers, manufacturers, and marketers, policy makers engaged in global inhalers products. Global inhalers market is surging owing to frequent acquisitions, product launch, and collaborations by the market players. For instance, in 2018, the company 3M has introduced an enhanced version of one rescue inhaler in the market.